Lateral flow tests are now the "gold standard" for rapid, take-at-home tests for COVID-19, but what are they, and how do they work? What is a lateral flow test?

Industry growth is fueled by a global rise in infectious diseases, an aging population, and increased adoption of home-based testing and point-of-care (POC) diagnostics Lateral Flow Assays Market ...

COVID testing is now available to everyone - irregardless of symptoms. Millions of people can order a twice-weekly rapid lateral flow test. What are the risks and benefits of doing so?

The rapid lateral-flow test for antigen detection can be obtained without prescription and will return results to the at-home user in 20 minutes, according to the FDA’s Dec. 15 statement.

The AffiDX® SARS-CoV-2 antigen lateral flow test has been developed using Avacta’s proprietary Affimer® platform to identify individuals with a higher viral load of the SARS-CoV-2 virus who ...

With Omicron overtaking Delta as the UK's dominant variant, some experts have raised concerns over whether lateral flow tests can effectively detect Omicron.

Rapid lateral flow tests aren't as accurate as polymerase chain reaction (PCR) tests at detecting the coronavirus.

The global lateral flow assay market is estimated at USD 8.2 billion in 2024 and is projected to reach USD 12.6 billion by 2030, expected to grow at a CAGR of 7.5% during the forecast period, ...